Atlas Trials

A Trial to Evaluate the Efficacy of Poziotinib, Pan HER Inhibitor in Recurrent/Metastatic Esophageal Cancer (R/M ESCC)

Clinical trial NCT03770988 · UNKNOWN

Trial details

NCT number
NCT03770988
Sponsor
Yonsei University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Inoperable or Recurrent or Metastatic Esophageal Squamous Carcinoma
Start date
2019-04-01
Primary completion
2020-08-31
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.